BioRestorative Therapies, Inc. , a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announces the engagement of Access BIO, L.C. to provide strategic preclinical and regulatory consulting services related to the Company's brtxDISC program. Initially Access BIO will help the Company prepare for pre-Investigational New Drug and IND meetings with the U.S. Food and Drug Administration .
http://www.freshnews.com/news/998158/biorestorative-therapies-engages-access-bio-support-advancement-brtxdisc-program-clinic
http://www.freshnews.com/news/998158/biorestorative-therapies-engages-access-bio-support-advancement-brtxdisc-program-clinic
No comments:
Post a Comment